Advertisement
Research Article| Volume 172, ISSUE 5, P449-453, November 1996

Download started.

Ok

The role of anticoagulation in pylephlebitis

  • Nicole Baril
    Affiliations
    From the Departments of Surgery, University of Southern California , USA

    Los Angeles County-University of Southern California Medical Center, Los Angeles, California, USA
    Search for articles by this author
  • Sherry Wren
    Correspondence
    Requests for reprints should be addressed to Steven Stain, MD, 1510 San Pablo Street, Suite 514, Los Angeles, California 90033.
    Affiliations
    From the Departments of Surgery, University of Southern California , USA

    Los Angeles County-University of Southern California Medical Center, Los Angeles, California, USA
    Search for articles by this author
  • Randall Radin
    Affiliations
    From the Radiology, University of Southern California, Los Angeles, California, USA

    Los Angeles County-University of Southern California Medical Center, Los Angeles, California, USA
    Search for articles by this author
  • Philip Ralls
    Affiliations
    From the Radiology, University of Southern California, Los Angeles, California, USA

    Los Angeles County-University of Southern California Medical Center, Los Angeles, California, USA
    Search for articles by this author
  • Steven Stain
    Affiliations
    From the Departments of Surgery, University of Southern California , USA

    Los Angeles County-University of Southern California Medical Center, Los Angeles, California, USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Background

      Pylephlebitis may complicate any intra-abdominal infection and carries a high mortality rate. Acute cases are usually anticoagulated to prevent thrombus extension and enteric ischemia; however, the role of anticoagulation has not been clearly defined.

      Methods

      Over a 3-year period, Pylephlebitis was diagnosed in 44 patients with portal vein thrombosis on computed tomography scan with fever, leukocytosis, and/or positive blood cultures. The charts were reviewed for etiology, extent of venous thrombosis, and method and results of treatment.

      Results

      Eighteen patients were hypercoagulable, due to clotting factor deficiencies (6), malignancy (8), or AIDS (4). Fifteen patients had mesenteric vein involvement. Thirty-two patients were not anticoagulated, and 5 died (3 with hypercoagulable states and 2 with normal clotting function). Twelve patients were anticoagulated, and none developed subsequent bowel infarction or died.

      Conclusion

      Patients with pylephlebitis and a hypercoagulable state due to neoplasms or clotting factor deficiencies should be anticoagulated. Patients with normal clotting function and mesenteric vein involvement may also benefit. We believe anticoagulation in patients with thrombus isolated to the portal vein and normal clotting function may be unnecessary.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bolt RJ
        Diseases of the hepatic blood vessels.
        in: Bockus HL Gastroenterology. 4th ed. WB Saunders, Philadelphia1985: 3259-3277
        • Duffy Jr, FJ
        • Millan MT
        • Schoetz Jr, DJ
        • Larsen CR
        Suppurative pylephlebitis and pylethrombosis: the role of anticoagulation.
        Am Surg. 1995; 61: 1041-1044
        • Drabick JJ
        • Landry FJ
        Suppurative pylephlebitis.
        South Med J. 1991; 84: 1396-1398
      1. NEJM. 1977; 296: 1051-1057
        • Giuliano CT
        • Zerykier A
        • Haller JO
        Pylephlebitis secondary to unsuspected appendiceal rupture.
        AJDC. 1989; 143: 1099-1100
        • Perez-Cruet MJ
        • Grable E
        • Drapkin MS
        • et al.
        Pylephlebitis associated with diverticulitis.
        South Med J. 1993; 86: 578-580
        • Soro Y
        Pylephlebitis and liver abscesses due to appendicitis.
        J Int Coll Surg. 1948; 115: 464-468
        • Harch JM
        • Radin RD
        • Yellin AE
        • Donovan AJ
        Pylethrombosis: serendipitous radiologic diagnosis.
        Arch Surg. 1987; 122: 1116-1119
        • Schwarz W
        • Honickman S
        • Ohki S
        • et al.
        Percutaneous diagnosis and drainage of pylephlebitis: a case report.
        Surgery. 1987; 101: 244-249
        • Van Gansebeke D
        • Avni EF
        • Delcour C
        • et al.
        Sonographic features of portal vein thrombosis.
        AJR. 1985; 144: 749-752
        • Mathieu D
        • Vasile N
        • Grenier P
        Portal thrombosis: dynamic CT features and course.
        Radiology. 1985; 154: 737-741
        • Pitt HA
        • Zuidema GD
        Factors influencing mortality in the treatment of pyogenic hepatic abscess.
        Surg Gynecol Obstet. 1975; 140: 228-234
        • Klatchko BA
        • Schwartz SI
        Diagnostic and therapeutic approaches to pyogenic abscess of the liver.
        Surg Gynecol Obstet. 1989; 168: 332-336
        • Bartley DL
        • Hughes WT
        • Parvey LS
        • Parham D
        CT of hepatic and fungal abscesses in leukemic children.
        Pediatr Infect Dis J. 1982; 1: 317-321
        • Bick RL
        Alterations of hemostasis in malignancy: etiology, pathophysiology, diagnosis and management.
        Semin Thromb Hemostas. 1978; 5: 1-26
        • Branum GD
        • Tyson GS
        • Branum MA
        • Meyers WC
        Hepatic abscess: changes in etiology, diagnosis and management.
        Ann Surg. 1990; 212: 655-662
        • Witte CL
        • Brewer ML
        • Witte MH
        • Pond GB
        Protean manifestations of pylethrombosis.
        Ann Surg. 1985; 202: 191-201
        • Bick RL
        • Pegrem M
        Syndromes of hypercoagulability and thrombosis: a review.
        Semin Thromb Hemostas. 1994; 20: 109-132
        • Valla D
        • Casadevall N
        • Huisse MG
        • et al.
        Etiology of portal vein thrombosis in adults, A prospective evaluation of primary myeloproliferative disorders.
        Gastroenterol. 1988; 94: 1C63-1069
        • Pokorney BH
        • Eyster ME
        • Jeffries GH
        Antithrombin III deficiency appearing as mesenteric venous thrombosis.
        Am J Gastroenterol. 1982; 76: 534-537
        • Johnson CC
        • Baggenstross AH
        Mesenteric vascular occlusion, Study of 99 cases of occlusion of veins.
        Mayo Clin Proc. 1949; 24: 628-636
        • Van Way III, CW
        • Brockman SK
        • Rosenfeld L
        Spontaneous thrombosis of the mesenteric veins.
        Ann Surg. 1971; 173: 561-568
        • Wessler S
        • Gitel SN
        Warfarin: from bedside to bench.
        NEJM. 1984; 311: 645-652